Increased serum extrachromosomal circular DNA SORBS1circle level is associated with insulin resistance in patients with newly diagnosed type 2 diabetes mellitus

Background Extrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance. However, the presence and impact of eccDNAs in type 2 diabetes mellitus (T2DM) remains inadequately understood. Methods We purified and sequenced...

Full description

Saved in:
Bibliographic Details
Published inCellular & molecular biology letters Vol. 29; no. 1; pp. 12 - 14
Main Authors Kong, Xiang, Wan, Shu-jun, Chen, Tian-bing, Jiang, Lan, Xing, Yu-jie, Bai, Ya-ping, Hua, Qiang, Yao, Xin-ming, Zhao, Yong-li, Zhang, Hong-mei, Wang, De-guo, Su, Qing, Lv, Kun
Format Journal Article
LanguageEnglish
Published London BioMed Central 12.01.2024
BMC
Subjects
Online AccessGet full text
ISSN1689-1392
1425-8153
1689-1392
DOI10.1186/s11658-023-00530-0

Cover

Abstract Background Extrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance. However, the presence and impact of eccDNAs in type 2 diabetes mellitus (T2DM) remains inadequately understood. Methods We purified and sequenced the serum eccDNAs obtained from newly diagnosed T2DM patients and normal control (NC) subjects using Circle-sequencing. We validated the level of a novel circulating eccDNA named sorbin and SH3‐domain‐ containing‐1 circle97206791–97208025 (SORBS1 circle ) in 106 newly diagnosed T2DM patients. The relationship between eccDNA SORBS1 circle and clinical data was analyzed. Furthermore, we explored the source and expression level of eccDNA SORBS1 circle in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. Results A total of 22,543 and 19,195 eccDNAs were found in serum samples obtained from newly diagnosed T2DM patients and NC subjects, respectively. The T2DM patients had a greater distribution of eccDNA on chromosomes 1, 14, 16, 17, 18, 19, 20 and X. Additionally, 598 serum eccDNAs were found to be upregulated, while 856 eccDNAs were downregulated in T2DM patients compared with NC subjects. KEGG analysis demonstrated that the genes carried by eccDNAs were mainly associated with insulin resistance. Moreover, it was validated that the eccDNA SORBS1 circle was significantly increased in serum of newly diagnosed T2DM patients (106 T2DM patients vs. 40 NC subjects). The serum eccDNA SORBS1 circle content was positively correlated with the levels of glycosylated hemoglobin A1C (HbA1C) and homeostasis model assessment of insulin resistance (HOMA-IR) in T2DM patients. Intracellular eccDNA SORBS1 circle expression was significantly enhanced in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. Moreover, the upregulation of eccDNA SORBS1 circle in the HG/PA-treated HepG2 cells was dependent on generation of apoptotic DNA fragmentation. Conclusions These results provide a preliminary understanding of the circulating eccDNA patterns at the early stage of T2DM and suggest that eccDNA SORBS1 circle may be involved in the development of insulin resistance.
AbstractList Extrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance. However, the presence and impact of eccDNAs in type 2 diabetes mellitus (T2DM) remains inadequately understood.BACKGROUNDExtrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance. However, the presence and impact of eccDNAs in type 2 diabetes mellitus (T2DM) remains inadequately understood.We purified and sequenced the serum eccDNAs obtained from newly diagnosed T2DM patients and normal control (NC) subjects using Circle-sequencing. We validated the level of a novel circulating eccDNA named sorbin and SH3-domain- containing-1circle97206791-97208025 (SORBS1circle) in 106 newly diagnosed T2DM patients. The relationship between eccDNA SORBS1circle and clinical data was analyzed. Furthermore, we explored the source and expression level of eccDNA SORBS1circle in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model.METHODSWe purified and sequenced the serum eccDNAs obtained from newly diagnosed T2DM patients and normal control (NC) subjects using Circle-sequencing. We validated the level of a novel circulating eccDNA named sorbin and SH3-domain- containing-1circle97206791-97208025 (SORBS1circle) in 106 newly diagnosed T2DM patients. The relationship between eccDNA SORBS1circle and clinical data was analyzed. Furthermore, we explored the source and expression level of eccDNA SORBS1circle in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model.A total of 22,543 and 19,195 eccDNAs were found in serum samples obtained from newly diagnosed T2DM patients and NC subjects, respectively. The T2DM patients had a greater distribution of eccDNA on chromosomes 1, 14, 16, 17, 18, 19, 20 and X. Additionally, 598 serum eccDNAs were found to be upregulated, while 856 eccDNAs were downregulated in T2DM patients compared with NC subjects. KEGG analysis demonstrated that the genes carried by eccDNAs were mainly associated with insulin resistance. Moreover, it was validated that the eccDNA SORBS1circle was significantly increased in serum of newly diagnosed T2DM patients (106 T2DM patients vs. 40 NC subjects). The serum eccDNA SORBS1circle content was positively correlated with the levels of glycosylated hemoglobin A1C (HbA1C) and homeostasis model assessment of insulin resistance (HOMA-IR) in T2DM patients. Intracellular eccDNA SORBS1circle expression was significantly enhanced in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. Moreover, the upregulation of eccDNA SORBS1circle in the HG/PA-treated HepG2 cells was dependent on generation of apoptotic DNA fragmentation.RESULTSA total of 22,543 and 19,195 eccDNAs were found in serum samples obtained from newly diagnosed T2DM patients and NC subjects, respectively. The T2DM patients had a greater distribution of eccDNA on chromosomes 1, 14, 16, 17, 18, 19, 20 and X. Additionally, 598 serum eccDNAs were found to be upregulated, while 856 eccDNAs were downregulated in T2DM patients compared with NC subjects. KEGG analysis demonstrated that the genes carried by eccDNAs were mainly associated with insulin resistance. Moreover, it was validated that the eccDNA SORBS1circle was significantly increased in serum of newly diagnosed T2DM patients (106 T2DM patients vs. 40 NC subjects). The serum eccDNA SORBS1circle content was positively correlated with the levels of glycosylated hemoglobin A1C (HbA1C) and homeostasis model assessment of insulin resistance (HOMA-IR) in T2DM patients. Intracellular eccDNA SORBS1circle expression was significantly enhanced in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. Moreover, the upregulation of eccDNA SORBS1circle in the HG/PA-treated HepG2 cells was dependent on generation of apoptotic DNA fragmentation.These results provide a preliminary understanding of the circulating eccDNA patterns at the early stage of T2DM and suggest that eccDNA SORBS1circle may be involved in the development of insulin resistance.CONCLUSIONSThese results provide a preliminary understanding of the circulating eccDNA patterns at the early stage of T2DM and suggest that eccDNA SORBS1circle may be involved in the development of insulin resistance.
BackgroundExtrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance. However, the presence and impact of eccDNAs in type 2 diabetes mellitus (T2DM) remains inadequately understood.MethodsWe purified and sequenced the serum eccDNAs obtained from newly diagnosed T2DM patients and normal control (NC) subjects using Circle-sequencing. We validated the level of a novel circulating eccDNA named sorbin and SH3‐domain‐ containing‐1circle97206791–97208025 (SORBS1circle) in 106 newly diagnosed T2DM patients. The relationship between eccDNA SORBS1circle and clinical data was analyzed. Furthermore, we explored the source and expression level of eccDNA SORBS1circle in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model.ResultsA total of 22,543 and 19,195 eccDNAs were found in serum samples obtained from newly diagnosed T2DM patients and NC subjects, respectively. The T2DM patients had a greater distribution of eccDNA on chromosomes 1, 14, 16, 17, 18, 19, 20 and X. Additionally, 598 serum eccDNAs were found to be upregulated, while 856 eccDNAs were downregulated in T2DM patients compared with NC subjects. KEGG analysis demonstrated that the genes carried by eccDNAs were mainly associated with insulin resistance. Moreover, it was validated that the eccDNA SORBS1circle was significantly increased in serum of newly diagnosed T2DM patients (106 T2DM patients vs. 40 NC subjects). The serum eccDNA SORBS1circle content was positively correlated with the levels of glycosylated hemoglobin A1C (HbA1C) and homeostasis model assessment of insulin resistance (HOMA-IR) in T2DM patients. Intracellular eccDNA SORBS1circle expression was significantly enhanced in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. Moreover, the upregulation of eccDNA SORBS1circle in the HG/PA-treated HepG2 cells was dependent on generation of apoptotic DNA fragmentation.ConclusionsThese results provide a preliminary understanding of the circulating eccDNA patterns at the early stage of T2DM and suggest that eccDNA SORBS1circle may be involved in the development of insulin resistance.
Abstract Background Extrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance. However, the presence and impact of eccDNAs in type 2 diabetes mellitus (T2DM) remains inadequately understood. Methods We purified and sequenced the serum eccDNAs obtained from newly diagnosed T2DM patients and normal control (NC) subjects using Circle-sequencing. We validated the level of a novel circulating eccDNA named sorbin and SH3‐domain‐ containing‐1circle97206791–97208025 (SORBS1circle) in 106 newly diagnosed T2DM patients. The relationship between eccDNA SORBS1circle and clinical data was analyzed. Furthermore, we explored the source and expression level of eccDNA SORBS1circle in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. Results A total of 22,543 and 19,195 eccDNAs were found in serum samples obtained from newly diagnosed T2DM patients and NC subjects, respectively. The T2DM patients had a greater distribution of eccDNA on chromosomes 1, 14, 16, 17, 18, 19, 20 and X. Additionally, 598 serum eccDNAs were found to be upregulated, while 856 eccDNAs were downregulated in T2DM patients compared with NC subjects. KEGG analysis demonstrated that the genes carried by eccDNAs were mainly associated with insulin resistance. Moreover, it was validated that the eccDNA SORBS1circle was significantly increased in serum of newly diagnosed T2DM patients (106 T2DM patients vs. 40 NC subjects). The serum eccDNA SORBS1circle content was positively correlated with the levels of glycosylated hemoglobin A1C (HbA1C) and homeostasis model assessment of insulin resistance (HOMA-IR) in T2DM patients. Intracellular eccDNA SORBS1circle expression was significantly enhanced in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. Moreover, the upregulation of eccDNA SORBS1circle in the HG/PA-treated HepG2 cells was dependent on generation of apoptotic DNA fragmentation. Conclusions These results provide a preliminary understanding of the circulating eccDNA patterns at the early stage of T2DM and suggest that eccDNA SORBS1circle may be involved in the development of insulin resistance.
Background Extrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance. However, the presence and impact of eccDNAs in type 2 diabetes mellitus (T2DM) remains inadequately understood. Methods We purified and sequenced the serum eccDNAs obtained from newly diagnosed T2DM patients and normal control (NC) subjects using Circle-sequencing. We validated the level of a novel circulating eccDNA named sorbin and SH3‐domain‐ containing‐1 circle97206791–97208025 (SORBS1 circle ) in 106 newly diagnosed T2DM patients. The relationship between eccDNA SORBS1 circle and clinical data was analyzed. Furthermore, we explored the source and expression level of eccDNA SORBS1 circle in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. Results A total of 22,543 and 19,195 eccDNAs were found in serum samples obtained from newly diagnosed T2DM patients and NC subjects, respectively. The T2DM patients had a greater distribution of eccDNA on chromosomes 1, 14, 16, 17, 18, 19, 20 and X. Additionally, 598 serum eccDNAs were found to be upregulated, while 856 eccDNAs were downregulated in T2DM patients compared with NC subjects. KEGG analysis demonstrated that the genes carried by eccDNAs were mainly associated with insulin resistance. Moreover, it was validated that the eccDNA SORBS1 circle was significantly increased in serum of newly diagnosed T2DM patients (106 T2DM patients vs. 40 NC subjects). The serum eccDNA SORBS1 circle content was positively correlated with the levels of glycosylated hemoglobin A1C (HbA1C) and homeostasis model assessment of insulin resistance (HOMA-IR) in T2DM patients. Intracellular eccDNA SORBS1 circle expression was significantly enhanced in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. Moreover, the upregulation of eccDNA SORBS1 circle in the HG/PA-treated HepG2 cells was dependent on generation of apoptotic DNA fragmentation. Conclusions These results provide a preliminary understanding of the circulating eccDNA patterns at the early stage of T2DM and suggest that eccDNA SORBS1 circle may be involved in the development of insulin resistance.
ArticleNumber 12
Author Jiang, Lan
Bai, Ya-ping
Zhang, Hong-mei
Wang, De-guo
Xing, Yu-jie
Yao, Xin-ming
Hua, Qiang
Kong, Xiang
Lv, Kun
Chen, Tian-bing
Wan, Shu-jun
Zhao, Yong-li
Su, Qing
Author_xml – sequence: 1
  givenname: Xiang
  orcidid: 0000-0003-1734-5171
  surname: Kong
  fullname: Kong, Xiang
  organization: Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Geriatric Endocrinology Unit, Department of Gerontology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Central Laboratory of Yijishan Hospital
– sequence: 2
  givenname: Shu-jun
  surname: Wan
  fullname: Wan, Shu-jun
  organization: Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Central Laboratory of Yijishan Hospital
– sequence: 3
  givenname: Tian-bing
  surname: Chen
  fullname: Chen, Tian-bing
  organization: Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Central Laboratory of Yijishan Hospital
– sequence: 4
  givenname: Lan
  surname: Jiang
  fullname: Jiang, Lan
  organization: Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Central Laboratory of Yijishan Hospital
– sequence: 5
  givenname: Yu-jie
  surname: Xing
  fullname: Xing, Yu-jie
  organization: Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Geriatric Endocrinology Unit, Department of Gerontology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital
– sequence: 6
  givenname: Ya-ping
  surname: Bai
  fullname: Bai, Ya-ping
  organization: Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College
– sequence: 7
  givenname: Qiang
  surname: Hua
  fullname: Hua, Qiang
  organization: Department of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital
– sequence: 8
  givenname: Xin-ming
  surname: Yao
  fullname: Yao, Xin-ming
  organization: Department of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital
– sequence: 9
  givenname: Yong-li
  surname: Zhao
  fullname: Zhao, Yong-li
  organization: Department of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital
– sequence: 10
  givenname: Hong-mei
  surname: Zhang
  fullname: Zhang, Hong-mei
  organization: Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine
– sequence: 11
  givenname: De-guo
  surname: Wang
  fullname: Wang, De-guo
  email: wangdeguo@medmail.com.cn
  organization: Geriatric Endocrinology Unit, Department of Gerontology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital
– sequence: 12
  givenname: Qing
  surname: Su
  fullname: Su, Qing
  email: suqing@xinhuamed.com.cn
  organization: Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine
– sequence: 13
  givenname: Kun
  surname: Lv
  fullname: Lv, Kun
  email: lvkun315@126.com
  organization: Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Central Laboratory of Yijishan Hospital
BookMark eNp9Ustu1TAUjFCRaAs_wMoSGzYB23nceFnK60oVlWj31olzcuvKsS8-Tsv9Gz4VpwGBuqg3tkYz4zP2nBRHPngsiteCvxOia9-TEG3TlVxWJedNxUv-rDgWbadKUSl59N_5RXFCdMu55HXNj4tfW28iAuHACOM8MfyZIpibGKZAYQLHjI1mdhDZx29n7Ory-4crsUAOmcM7dMwSA6JgLKRscm_TDbOeZmc9i0iWEniDGWJ7SBZ9opXj8d4d2GBh58NyezrskckF6DEhsQmds2mml8XzERzhqz_7aXH9-dP1-dfy4vLL9vzsojQ5VCpNN9ZQNa0xG9Ubg2KEio84StE3efVj02AroIcB0Ww63DQb2fNW1V1T1XVdnRbb1XYIcKv30U4QDzqA1Q9AiDsNMdkcW3eopOIKVAVtjRz7QbRG1sYMI-_aBrLX29VrH8OPGSnpyZLJecBjmElLJWrZ5LHbTH3ziHob5uhz0IVVSaVqsQzXrSwTA1HEURub8msGn__KOi24Xlqg1xbo3AL90ALNs1Q-kv7N9qSoWkWUyX6H8d9UT6h-A1u9yc8
CitedBy_id crossref_primary_10_1080_15592294_2025_2477903
crossref_primary_10_1186_s12933_024_02381_1
crossref_primary_10_1007_s13577_025_01178_y
crossref_primary_10_1016_j_yexcr_2024_114318
crossref_primary_10_1159_000541563
crossref_primary_10_1186_s12943_024_02187_5
crossref_primary_10_1186_s11658_024_00616_3
crossref_primary_10_3390_biom14040488
Cites_doi 10.1038/s41598-017-11368-w
10.1186/s11658-022-00397-7
10.1038/s41580-018-0044-8
10.1038/s41419-022-04807-8
10.1038/s41419-022-04627-w
10.1038/35025089
10.1186/s11658-021-00276-7
10.1186/s40001-023-01064-z
10.1136/bmjdrc-2019-001078
10.1038/s41467-018-03369-8
10.4093/dmj.2017.0082
10.1002/dmrr.3524
10.1016/j.cell.2019.10.039
10.1093/nar/gkab984
10.1158/1541-7786.MCR-17-0095
10.1073/pnas.1914949117
10.1002/ctm2.817
10.3390/ijms22042151
10.1038/s41598-018-28891-z
10.2337/dc19-S002
10.1186/s13045-020-00960-9
10.1371/journal.pone.0222278
10.1097/HEP.0000000000000435
10.1038/s41586-021-04009-w
ContentType Journal Article
Copyright The Author(s) 2024
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024. The Author(s).
Copyright_xml – notice: The Author(s) 2024
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024. The Author(s).
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
88A
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
DOA
DOI 10.1186/s11658-023-00530-0
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection (UHCL Subscription)
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (UHCL Subscription)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DOAJ Open Access Full Text
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1689-1392
EndPage 14
ExternalDocumentID oai_doaj_org_article_8e92909a93a64e0ebd16c24ccdf0865a
10_1186_s11658_023_00530_0
GeographicLocations England
United Kingdom--UK
United States--US
China
Japan
Germany
GeographicLocations_xml – name: England
– name: China
– name: Germany
– name: United Kingdom--UK
– name: United States--US
– name: Japan
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81970699
  funderid: http://dx.doi.org/10.13039/501100001809
GroupedDBID ---
.86
.VR
06D
0R~
0VY
29B
2JY
2~H
30V
4.4
408
53G
5GY
67N
67Z
6NX
6S1
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95.
95~
AAFWJ
AAJSJ
AAKDD
AAQCX
AASML
AASQH
AAXMT
ABAQN
ABFKT
ABMNI
ABUWG
ACGFS
ACOMO
ACPRK
ACZBO
ADBBV
ADGYE
ADOZN
ADUKV
AENEX
AFBAA
AFBBN
AFCXV
AFKRA
AFPKN
AFWTZ
AHBYD
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BA0
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
C6C
CCPQU
CS3
DU5
E3Z
EBLON
EBS
EMOBN
F5P
FRP
FYUFA
G-Y
G-Z
GQ7
GROUPED_DOAJ
GX1
HCIFZ
HF~
HLICF
HMCUK
HMJXF
HYE
IJ-
IXC
IXE
IY9
IZQ
I~X
I~Z
KDC
KOV
M1P
M7P
MA-
N9A
OAM
OK1
PF0
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PSQYO
PUEGO
Q2X
QOS
R9I
RBZ
RNS
ROL
RPM
RPX
RSV
S27
S3A
S3B
SBL
SDH
SHX
SOJ
T13
TR2
TSK
TSV
TUC
U2A
UKHRP
VC2
WK8
XSB
~A9
AAYXX
ALIPV
CITATION
Y2W
3V.
7XB
88A
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
K9.
LK8
PKEHL
PQEST
PQQKQ
PQUKI
7X8
ID FETCH-LOGICAL-c392t-c8f4a356cc79bcce1fa30fef21b5555bf55e61abadeec78e7572b06948534443
IEDL.DBID C6C
ISSN 1689-1392
1425-8153
IngestDate Wed Aug 27 01:13:05 EDT 2025
Thu Sep 04 17:10:50 EDT 2025
Fri Jul 25 18:56:45 EDT 2025
Tue Jul 01 03:25:18 EDT 2025
Thu Apr 24 23:04:02 EDT 2025
Sat Sep 06 07:21:52 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords T2DM
Insulin resistance
Extrachromosomal circular DNAs
SORBS1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c392t-c8f4a356cc79bcce1fa30fef21b5555bf55e61abadeec78e7572b06948534443
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-1734-5171
OpenAccessLink https://doi.org/10.1186/s11658-023-00530-0
PQID 2913299414
PQPubID 54771
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_8e92909a93a64e0ebd16c24ccdf0865a
proquest_miscellaneous_2914253926
proquest_journals_2913299414
crossref_citationtrail_10_1186_s11658_023_00530_0
crossref_primary_10_1186_s11658_023_00530_0
springer_journals_10_1186_s11658_023_00530_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-12
PublicationDateYYYYMMDD 2024-01-12
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-12
  day: 12
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: Wrocław
PublicationTitle Cellular & molecular biology letters
PublicationTitleAbbrev Cell Mol Biol Lett
PublicationYear 2024
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References Y Wang (530_CR9) 2021; 599
American Diabetes Association (530_CR14) 2019; 42
Q Yang (530_CR24) 2018; 19
M Arosemena (530_CR12) 2021; 22
JM Kim (530_CR15) 2018; 42
LV Yuzefovych (530_CR13) 2019; 14
T Paulsen (530_CR16) 2021; 49
P Kumar (530_CR3) 2017; 15
TS Sayed (530_CR18) 2022; 27
C Lin (530_CR8) 2022; 13
J Zhao (530_CR17) 2021; 26
AR Morton (530_CR4) 2019; 179
W Lv (530_CR2) 2022; 12
S Gong (530_CR22) 2022; 38
S Zou (530_CR6) 2023
Y Peng (530_CR10) 2023; 28
Y Yan (530_CR7) 2020; 13
STK Sin (530_CR20) 2020; 117
TJ Chang (530_CR23) 2018; 8
J Zhu (530_CR19) 2017; 7
CA Baumann (530_CR21) 2000; 407
HD Møller (530_CR1) 2018; 9
Y Cen (530_CR5) 2022; 13
X Li (530_CR11) 2020; 8
References_xml – volume: 7
  start-page: 10968
  issue: 1
  year: 2017
  ident: 530_CR19
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-11368-w
– volume: 27
  start-page: 103
  issue: 1
  year: 2022
  ident: 530_CR18
  publication-title: Cell Mol Biol Lett
  doi: 10.1186/s11658-022-00397-7
– volume: 19
  start-page: 654
  issue: 10
  year: 2018
  ident: 530_CR24
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-018-0044-8
– volume: 13
  start-page: 342
  issue: 4
  year: 2022
  ident: 530_CR5
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-022-04807-8
– volume: 13
  start-page: 171
  issue: 2
  year: 2022
  ident: 530_CR8
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-022-04627-w
– volume: 407
  start-page: 202
  issue: 6801
  year: 2000
  ident: 530_CR21
  publication-title: Nature
  doi: 10.1038/35025089
– volume: 26
  start-page: 32
  issue: 1
  year: 2021
  ident: 530_CR17
  publication-title: Cell Mol Biol Lett
  doi: 10.1186/s11658-021-00276-7
– volume: 28
  start-page: 134
  issue: 1
  year: 2023
  ident: 530_CR10
  publication-title: Eur J Med Res
  doi: 10.1186/s40001-023-01064-z
– volume: 8
  issue: 1
  year: 2020
  ident: 530_CR11
  publication-title: BMJ Open Diabetes Res Care
  doi: 10.1136/bmjdrc-2019-001078
– volume: 9
  start-page: 1069
  issue: 1
  year: 2018
  ident: 530_CR1
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-03369-8
– volume: 42
  start-page: 343
  issue: 4
  year: 2018
  ident: 530_CR15
  publication-title: Diabetes Metab J
  doi: 10.4093/dmj.2017.0082
– volume: 38
  year: 2022
  ident: 530_CR22
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/dmrr.3524
– volume: 179
  start-page: 1330
  issue: 6
  year: 2019
  ident: 530_CR4
  publication-title: Cell
  doi: 10.1016/j.cell.2019.10.039
– volume: 49
  start-page: 11787
  issue: 20
  year: 2021
  ident: 530_CR16
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkab984
– volume: 15
  start-page: 1197
  issue: 9
  year: 2017
  ident: 530_CR3
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-17-0095
– volume: 117
  start-page: 1658
  issue: 3
  year: 2020
  ident: 530_CR20
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1914949117
– volume: 12
  issue: 4
  year: 2022
  ident: 530_CR2
  publication-title: Clin Transl Med
  doi: 10.1002/ctm2.817
– volume: 22
  start-page: 2151
  issue: 4
  year: 2021
  ident: 530_CR12
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22042151
– volume: 8
  start-page: 10574
  year: 2018
  ident: 530_CR23
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-28891-z
– volume: 42
  start-page: S13
  issue: Suppl 1
  year: 2019
  ident: 530_CR14
  publication-title: Diabetes Care
  doi: 10.2337/dc19-S002
– volume: 13
  start-page: 124
  issue: 1
  year: 2020
  ident: 530_CR7
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-020-00960-9
– volume: 14
  issue: 10
  year: 2019
  ident: 530_CR13
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0222278
– year: 2023
  ident: 530_CR6
  publication-title: Hepatology
  doi: 10.1097/HEP.0000000000000435
– volume: 599
  start-page: 308
  issue: 7884
  year: 2021
  ident: 530_CR9
  publication-title: Nature
  doi: 10.1038/s41586-021-04009-w
SSID ssj0020440
Score 2.391235
Snippet Background Extrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance....
BackgroundExtrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance....
Extrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance. However, the...
Abstract Background Extrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug...
SourceID doaj
proquest
crossref
springer
SourceType Open Website
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 12
SubjectTerms Antibodies
Apoptosis
Biochemistry
Biological and Medical Physics
Biomedical and Life Sciences
Biophysics
Biotechnology
Brief Report
Cell Biology
Cholesterol
Chronic illnesses
Circular DNA
Diabetes
Diabetes mellitus (non-insulin dependent)
DNA fragmentation
Drug resistance
Extrachromosomal circular DNAs
Genomes
Glucose
Hemoglobin
Homeostasis
Hospitals
Hybridization
Insulin resistance
Kinases
Life Sciences
Mitochondrial DNA
Molecular Medicine
Palmitic acid
Software
Somatic cells
SORBS1
T2DM
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOgl9Ek3TYoKvaUmkizJ9jFpE0KhCTQp5Cb0JIF9lPXuIf-mPzUzsrxtCkkv9VGWjNDMeL6RRt8Q8jHqBrwWD5VvOgcBSg02F6yokPpL6LoWtcLLyd_O9OkP-fVKXf1R6gtzwgZ64GHhDtoIDpx1tqutlpFFF7j2QnofEqBxlaER69gYTJVQCwspj1dkWn3QI8lMW4F_qlDrWMXuuaHM1n8PYv51Kpqdzclzsl1QIj0cZveCPInzl-TpUDfy9hX5BVaNyeQxUNCg9YzCH3Zp_TWm1vWLGYz0N8ucYEq_nB3Si_PvRxccm6aRTjFLiN701BbBwEdwM5aWrHQK8TdiSlAGaKKFd7Uf-gAGn97SMKTnwUDcwKWCjhu4dIb0nqt1_5pcnhxffj6tSqmFygNAWlW-TdLWSnsUmfeRJ1uzFJPgTsHjklJRc-tsiNE3bWxUIxzemQVvL6Ws35Ct-WIe3xIqXUoAY1zLbZK8DV1gWojAlRc6qoZNCB8X3vhCQ47VMKYmhyOtNoOwDAjLZGEZGLO_GfNzIOF4tPcRynPTEwm0cwOolSlqZf6lVhOyO2qDKVbdG9FB7N51kssJ-bB5DfaIhyx2Hhfr3Ad-g7CoekI-jVr0-xMPT3vnf0z7HXkmAHXhHhEXu2RrtVzHPUBNK_c-G8gda7wT-g
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELagCIkLojxEoCAjcQOra6_t3T2hFlpVlSgSLVJull9LKyXZkk0O_Tf8VGa83kRFanN07E20M-P5Zjz-hpCPUVfgtXhgvmocBCgl2FywgiH1l9BlKUqFl5O_n-mTX_J0qqY54dbnsspxT0wbdeg85sj3RYMt0RvJ5ZfrPwy7RuHpam6h8ZA8StRloM_VdBtwYTvldLtIKFaDaY-XZmq93yPtTM3AYzHUw4IVtxxT4u-_BTr_OydN7uf4GXmacSM9GAS9Sx7ExXPyeOgkefOC_AU7x_LyGCjo1HpOYc9dWn-JxXZ9N4eV_mqZSk7pt7MDev7j5-E5x6FZpDOsG6JXPbVZVPAQTM_SXKdOISJHlAnqAUM0M7H2wxxA5bMbGoaCPViIKV0q6JjSpXMk_Fyt-5fk4vjo4usJy80XmAfItGK-bqUtlfYoRO8jb21ZtLEV3Cn4uFapqLl1NsToqzpWqhIOb9GC_5dSlq_IzqJbxNeESte2AGxczW0reR2aUGghAlde6KiqYkL4-OKNz8Tk2B9jZlKAUmszCMuAsEwSloE1nzZrrgdajntnH6I8NzORUjsNdMvfJluoqSMgxaKxTWm1jEV0gWsvpPehhbBP2QnZG7XBZDvvzVYrJ-TD5muwUDx2sYvYrdMcUEB4qXpCPo9atH3E3X_7zf2_-JY8EYCwMB_ExR7ZWS3X8R0gpJV7n8zgH8vtDNc
  priority: 102
  providerName: ProQuest
Title Increased serum extrachromosomal circular DNA SORBS1circle level is associated with insulin resistance in patients with newly diagnosed type 2 diabetes mellitus
URI https://link.springer.com/article/10.1186/s11658-023-00530-0
https://www.proquest.com/docview/2913299414
https://www.proquest.com/docview/2914253926
https://doaj.org/article/8e92909a93a64e0ebd16c24ccdf0865a
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9RAEG50F8GL-MTRdWjBmwbTzyTHmXWXRXCUfcDcmn4FF-Yhk5nD_ht_qlWdzuiKCuaQQ6cqhK6q1FfV1dWEvIm6Aq_FQuGrxkGAIsDmguUFtv7iWgguFG5O_jTTZ1fy41zNc5sc3Avz6_o9q_X7DtvD1AV4lgL1pSwgPD9UTOi0MKuP98EVHp08bIr5I98tx5P6898Clb-tgyb3cvqQPMi4kE56QT4id-LqMbnXnxR584R8BzvG8vEYKOjMbknhn7qx_isW03XrJXD6600qKaUfZhN68fl8esFwaBHpAuuC6HVHbRYFvATTrzTXoVOIuBFFgvhhiOZOq11PA6h7cUNDX5AHjJiypZwOKVu6xIae2133lFyenlwenxX5cIXCAyTaFr5upRVKexSS95G1VpRtbDlzCi7XKhU1s86GGH1Vx0pV3OEuWfDvUkrxjBys1qv4nFDp2haAi6uZbSWrQxNKzXlgynMdVVWOCBsm3vjceBzPv1iYFIDU2vTCMiAsk4RlgOftnudb33bjn9RTlOeeEltmpwHQJJMt0NQRkGDZ2EZYLWMZXWDac-l9aCGsU3ZEjgZtMNmOO8MbiNabRjI5Iq_3j8ECcVnFruJ6l2jgxweTqkfk3aBFP1_x989-8X_kL8l9DogK8z-MH5GD7WYXXwEi2roxuVvNqzE5nJ7MvpyPk2GMU3YB7ld88gM7Oggd
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJwQviKsoDDASPIG12LGd5AGhlW3q2FbQVqS9WY7twKReRtIK9d_wB_iPnJNLpyGxt_XRtZ0o5_O5-VwIeRN0AlKLe-aSLAcDJYYz561gWPpL6DgWscLk5OORHn6Tn8_U2Qb50-XCYFhlxxNrRu3nDn3k2yLDluiZ5PLjxU-GXaPwdrVrodHA4jCsfoHJVn042AX6vhVif2_8acjargLMgS6wYC4tpI2Vdvh2zgVe2DgqQiF4ruCXF0oFzW1ufQguSUOiEpFjeigINillDNveIpsSE1p7ZHOwN_p6srbwsH9znc4kFEuBl3RZOqnerrDOTcpARDIEfsSiK5KwbhhwRcv952K2lnf798m9VlGlOw2yHpCNMHtIbjetK1ePyG9gLBjPHjwFEC-nFJh8ad0PjO6r5lNY6c7LOsaV7o526OmXk8Epx6FJoBMMVKLnFbUtNmAT9AfTNjCelqFCtRbwCEO0Lf1aNXPADJisqG8iBGEh-pCpoJ0PmU6xwuhiWT0m45ugyxPSm81n4SmhMi8K0KTylNtC8tRnPtJCeK6c0EElUZ_w7sMb11ZCx4YcE1NbRKk2DbEMEMvUxDKw5t16zUVTB-Ta2QOk53om1vCuB-bld9OyBJMGUE2jzGax1TJEIfdcOyGd8wXYmcr2yVaHBtMylspcHoM-eb3-G1gC3vPYWZgv6zkAQPiouk_edyi63OL_r_3s-ie-IneG4-Mjc3QwOnxO7gpQ79AZxcUW6S3KZXgB6tkif9keCkrMDR_Dv0Q-S7Y
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1BpDIF4QV61sgJHgCazGju0kDwhtlGpjUBAbUt8sx3ZgUi9b0gr1b_gN_o5zcmk1JPa2PDq2E_ncj8-FkJdBJyC1uGcuyXIwUGKgOW8Fw9JfQsexiBUmJ38e6cPv8uNYjbfIny4XBsMqO55YM2o_d-gj74sMW6Jnkst-0YZFfB0M351fMOwghTetXTuNBkWOw-oXmG_V26MBwPqVEMMPp-8PWdthgDnQCxbMpYW0sdIO_9S5wAsbR0UoBM8VPHmhVNDc5taH4JI0JCoROaaKgpCTUsaw7Q1yM4lBqQJSSsYbWw87OdeJTUKxFLhKl6-T6n6FFW9SBsKSIQlELLokE-vWAZf03X-uaGvJN7xH7rYqK91vcOw-2QqzB-RW08Ry9ZD8BhaDke3BU0Dn5ZTCmZXW_cQ4v2o-hZXurKyjXelgtE9Pvnw7OOE4NAl0giFL9KyitsUS2AQ9w7QNkadlqFDBBcyEIdoWga2aOWAQTFbUN7GCsBC9yVTQzptMp1hrdLGsHpHT64DKY7I9m8_CDqEyLwrQqfKU20Ly1Gc-0kJ4rpzQQSVRj_Du4I1ra6Jja46JqW2jVJsGWAaAZWpgGVjzer3mvKkIcuXsA4TneiZW864H5uUP0zIHkwZQUqPMZrHVMkQh91w7IZ3zBVicyvbIXocNpmUxldkQRI-8WL8G5oA3PnYW5st6DiAgHKrukTcdFm22-P9vP7n6i8_JbSA-8-lodLxL7gjQ89ArxcUe2V6Uy_AU9LRF_qymCErMNVPgX-tUTn0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+serum+extrachromosomal+circular+DNA+SORBS1circle+level+is+associated+with+insulin+resistance+in+patients+with+newly+diagnosed+type+2+diabetes+mellitus&rft.jtitle=Cellular+%26+molecular+biology+letters&rft.au=Kong%2C+Xiang&rft.au=Wan%2C+Shu-jun&rft.au=Chen%2C+Tian-bing&rft.au=Jiang%2C+Lan&rft.date=2024-01-12&rft.pub=BioMed+Central&rft.eissn=1689-1392&rft.volume=29&rft.issue=1&rft_id=info:doi/10.1186%2Fs11658-023-00530-0&rft.externalDocID=10_1186_s11658_023_00530_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1689-1392&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1689-1392&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1689-1392&client=summon